HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Margaret S Wu Selected Research

2- (2- chloro- 5- ((3- (4- chlorophenoxy)- 2- methyl- 6- (trifluoromethoxy)- 1H- indol- 1- yl)methyl)phenoxy)propionic acid

4/2008A novel selective peroxisome proliferator-activator receptor-gamma modulator-SPPARgammaM5 improves insulin sensitivity with diminished adverse cardiovascular effects.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Margaret S Wu Research Topics

Disease

3Type 2 Diabetes Mellitus (MODY)
01/2017 - 06/2004
1Obesity
10/2010
1Cardiomegaly (Heart Hypertrophy)
04/2008
1Hyperlipidemias (Hyperlipidemia)
04/2008
1Insulin Resistance
04/2008
1Hyperglycemia
05/2004
1Hyperinsulinism (Hyperinsulinemia)
05/2004

Drug/Important Bio-Agent (IBA)

2Pioglitazone (Actos)FDA Link
04/2008 - 05/2004
1Glucose (Dextrose)FDA LinkGeneric
01/2017
1malonyl-CoA decarboxylaseIBA
10/2010
12- (2- chloro- 5- ((3- (4- chlorophenoxy)- 2- methyl- 6- (trifluoromethoxy)- 1H- indol- 1- yl)methyl)phenoxy)propionic acidIBA
04/2008
1Insulin (Novolin)FDA Link
04/2008
1Rosiglitazone (Avandia)FDA Link
04/2008
12,4-thiazolidinedione (thiazolidinedione)IBA
04/2008
1LipidsIBA
06/2004
1Hypoglycemic Agents (Hypoglycemics)IBA
06/2004
1MK0767IBA
05/2004

Therapy/Procedure

1Glycemic Control
04/2008